Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
22m agoUFP Industries Expands Pallet Manufacturing Network Through Acquisition
23m agoPodcastOne (Nasdaq: PODC) Anticipates Record FY 2026 Results of $61M+ Revenue and $6.3M+ Adjusted EBITDA*, Up +1,476% YOY
48m agoLinkhome Holdings Inc. Signs MOU to Acquire Mortgage One Group, Accelerating Nationwide Expansion of AI Real Estate & Fintech Platform
48m agoDeluxe and MRI Software Partner to Enhance Payment Capabilities for Property Management Companies
50m agoBox Launches Box Automate to Orchestrate Agentic Workflows
Bioage Labs, Inc logo

Bioage Labs, Inc

About

Bioage Labs, Inc (NASDAQ:BIOA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
Apr 13 2026
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Mar 24 2026
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
Feb 19 2026
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 9 2026
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China

Financials

Revenue
$8.99 M
Market Cap
$777.98 M
EPS
-2.24

Community Chat

Ask AI

6ix6ix